Atsuko Watanabe
Comptroller/Controller/Auditor bei HanaVax, Inc.
Aktive Positionen von Atsuko Watanabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
HanaVax, Inc.
 HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Comptroller/Controller/Auditor | 01.11.2018 | - |
Karriereverlauf von Atsuko Watanabe
Ehemalige bekannte Positionen von Atsuko Watanabe
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ONCOTHERAPY SCIENCE, INC. | Direktor/Vorstandsmitglied | 01.06.2019 | - |
| Corporate Officer/Principal | 01.05.2019 | - |
Statistik
International
| Japan | 3 |
Operativ
| Director/Board Member | 1 |
| Corporate Officer/Principal | 1 |
| Comptroller/Controller/Auditor | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ONCOTHERAPY SCIENCE, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
HanaVax, Inc.
HanaVax, Inc. BiotechnologyHealth Technology HanaVax, Inc. develops nasal vaccine against infectious diseases. It develops pneumococcal nasal vaccine to prevent pneumonia, sepsis and otitis media. The company was founded by Hosei Ou on December 27, 2017 and is headquartered in Tokyo, Japan. | Health Technology |
- Börse
- Insiders
- Atsuko Watanabe
- Erfahrung
